Approval Year
| Substance Class |
Protein
Created
by
admin
on
Edited
Mon Mar 31 22:55:32 GMT 2025
by
admin
on
Mon Mar 31 22:55:32 GMT 2025
|
| Protein Type | MONOCLONAL ANTIBODY |
| Protein Sub Type | IGG1 |
| Sequence Origin | HUMANIZED MOUSE |
| Sequence Type | COMPLETE |
| Record UNII |
Y6M3205516
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
CD-100
Created by
admin on Mon Mar 31 22:55:32 GMT 2025 , Edited by admin on Mon Mar 31 22:55:32 GMT 2025
|
PRIMARY | |||
|
CHEMBL3707404
Created by
admin on Mon Mar 31 22:55:32 GMT 2025 , Edited by admin on Mon Mar 31 22:55:32 GMT 2025
|
PRIMARY | |||
|
Lumretuzumab
Created by
admin on Mon Mar 31 22:55:32 GMT 2025 , Edited by admin on Mon Mar 31 22:55:32 GMT 2025
|
PRIMARY | |||
|
SUB177214
Created by
admin on Mon Mar 31 22:55:32 GMT 2025 , Edited by admin on Mon Mar 31 22:55:32 GMT 2025
|
PRIMARY | |||
|
DB12683
Created by
admin on Mon Mar 31 22:55:32 GMT 2025 , Edited by admin on Mon Mar 31 22:55:32 GMT 2025
|
PRIMARY | |||
|
Y6M3205516
Created by
admin on Mon Mar 31 22:55:32 GMT 2025 , Edited by admin on Mon Mar 31 22:55:32 GMT 2025
|
PRIMARY | |||
|
100000163088
Created by
admin on Mon Mar 31 22:55:32 GMT 2025 , Edited by admin on Mon Mar 31 22:55:32 GMT 2025
|
PRIMARY | |||
|
CHEMBL2109441
Created by
admin on Mon Mar 31 22:55:32 GMT 2025 , Edited by admin on Mon Mar 31 22:55:32 GMT 2025
|
PRIMARY | |||
|
9952
Created by
admin on Mon Mar 31 22:55:32 GMT 2025 , Edited by admin on Mon Mar 31 22:55:32 GMT 2025
|
PRIMARY | |||
|
1448327-63-6
Created by
admin on Mon Mar 31 22:55:32 GMT 2025 , Edited by admin on Mon Mar 31 22:55:32 GMT 2025
|
PRIMARY | |||
|
C104058
Created by
admin on Mon Mar 31 22:55:32 GMT 2025 , Edited by admin on Mon Mar 31 22:55:32 GMT 2025
|
PRIMARY |
| From | To |
|---|---|
| 1_22 | 1_96 |
| 1_147 | 1_203 |
| 1_264 | 1_324 |
| 1_370 | 1_428 |
| 2_22 | 2_96 |
| 2_147 | 2_203 |
| 2_264 | 2_324 |
| 2_370 | 2_428 |
| 3_23 | 3_94 |
| 3_140 | 3_200 |
| 4_23 | 4_94 |
| 4_140 | 4_200 |
| 1_223 | 3_220 |
| 2_223 | 4_220 |
| 1_229 | 2_229 |
| 1_232 | 2_232 |
| Glycosylation Link Type | Site |
|---|---|
| N | 1_300 |
| N | 2_300 |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
TARGET -> INHIBITOR |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
Structural Modifications
| Modification Type | Location Site | Location Type | Residue Modified | Extent | Fragment Name | Fragment Approval |
|---|---|---|---|---|---|---|
| AMINO_ACID_SUBSTITUTION | [1_1] [2_1] | 5'-TERMINUS | PIDOLIC ACID | SZB83O1W42 |
| Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
|---|---|---|---|---|---|---|
| MOL_WEIGHT:NUMBER(CALCULATED) | CHEMICAL |
|
||||
| Molecular Formula | CHEMICAL |
|